Sponsor Pipeline

Lexeo Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
3
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-22 NCT07721025 Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy Phase 2 Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07721025 Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy Friedreich Ataxia Recruiting
Phase 1/2
NCT06109181 Gene Therapy for ACM Due to a PKP2 Pathogenic Variant Arrhythmogenic Cardiomyopathy Active, Not Recruiting
NCT05445323 Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia Friedreich Ataxia Active, Not Recruiting
Phase 1
NCT05400330 Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease Alzheimer Disease Active, Not Recruiting
Not specified
NCT06976606 A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic… Arrhythmogenic Cardiomyopathy Recruiting
NCT06865482 Clinical Course Of Disease In Participants With FA-CM Friedreich Ataxia Recruiting
NCT07050160 Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a… Arrhythmogenic Cardiomyopathy Enrolling by Invitation
Disease Areas
Alzheimer's Disease (1)
Get alerts when Lexeo Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free